Hearing aids are now available over the counter from Walgreens, CVS and Best Buy

Hearing aids are now available over the counter from Walgreens, CVS and Best Buy


Jennifer Nealon, Marketing Director at Hear Again America, holds hearing aids that they sell on October 19, 2021 in Boca Raton, Florida.

Joe Raedle | Getty Images

Millions of Americans with hearing loss can now purchase hearing aids without a prescription or medical exam from Walgreens, CVS and Best Buy , according to the companies.

Walgreens on Monday started selling over-the-counter hearing aids online and at its stores nationwide for $799 a pair. By comparison, the average cost of prescription hearing aids can range between $2,000 and $8,000, according to the company.

CVS is selling over-the-counter devices on its website with prices ranging from $199 to $999. The drug store chain will start also offering them at select pharmacy locations beginning in November.

Best Buy is offering 20 different over-the-counter hearing aids online with prices ranging from $200 to $3,000, according to the company. The electronics retailer will offer the devices in 300 stores across the country later this month.

And Hy-Vee, a supermarket chain, will offer four different hearing aids online and in 34 locations across Iowa, Kansas, Minnesota, Missouri, Nebraska and Wisconsin this week. Prices range from $499 to $999. By the end of the year, the devices will be available in 100 stores.

The Food and Drug Administration issued a rule in August that allowed over-the-counter sales of hearing aids for adults ages 18 and older with mild to moderate hearing loss. People with severe hearing loss and children still need prescriptions for the devices.

President Joe Biden had issued an executive order in 2021 directing the Health and Human Services Department and FDA to develop a rule allowing over-the-counter sales of hearing aids. The White House announced the availability of the hearing aids earlier Monday.

Some 30 million people in the U.S. have hearing loss but only about one-fifth of these individuals have hearing aids and use them, according to FDA. Many people who could benefit from the devices either can’t access them due to cost while other people don’t use them due to perceived stigma, according the agency.

The FDA, in analysis, estimated that over-the-counter hearing aids could save consumers about $1,438 because they are not bundled with costly professional services.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Health

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit

The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating their obesity with GLP-1 drugs. Early on, there were manufacturing bottlenecks that resulted in short supplies of Novo Nordisk ‘s Wegovy and Eli Lilly ‘s Zepbound. There were insurance coverage issues for these pricey treatments, […]

Read More
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More